Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324137029> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4324137029 endingPage "388" @default.
- W4324137029 startingPage "388" @default.
- W4324137029 abstract "388 Background: IsoPSA is prospectively validated to be superior to PSA and percent free PSA in predicting prostate cancer (PCa) as well as clinically significant prostate cancer. We sought to evaluate the use of IsoPSA in combination with prostate magnetic resonance imaging (MRI) and the prostate imaging reporting and data systems (PIRADS) on predicting either benign/indolent or csPCA at biopsy. Methods: This was a single center retrospective review of prospectively collected patient data that included all patients who underwent IsoPSA testing, preoperative prostate MRI and prostate biopsy from 2019-2021. Chi Squared analysis was used to assess for associations between a binary classification of low (<6) or elevated (>6) IsoPSA index, in combination with PIRADS scores in predicting either indolent/benign or csPCa at biopsy. Logistic regression was used to explore independent predictors of csPCa. Receiver Operating Curve (ROC) analysis was completed with areas under the curve (AUC) for IsoPSA and PIRADS scores, both alone and in combination. Predictive probabilities were assessed using combinations of IsoPSA thresholds and PIRADS scores. Results: 207 patients met inclusion criteria. Among patients with a negative MRI, low IsoPSA index was associated with a lower chance of csPCa compared to those with elevated IsoPSA (2% vs 15%, p<0.018). For those with a PIRADS 4-5 lesion, elevated IsoPSA index was associated with a higher chance of csPCa at biopsy compared to a low IsoPSA index (49% vs 19%, p=0.05). On multivariate analysis, elevated IsoPSA and PIRADS 4-5 were independent predictors of csPCa (p<0.001). Similarly, low IsoPSA index and negative MRI were independent predictors of benign/indolent disease at biopsy (p<0.001). Using predictive probabilities, the combination of PIRADS 4-5 with elevated IsoPSA was associated with the highest risk of csPCa (48%) and the highest AUC (0.83) for predicting csPCa. This AUC value was superior to either marker alone (0.76, 0.76) and total PSA alone (0.57) (p<0.001). Conclusions: The combination of elevated IsoPSA with adverse PIRADS score (4-5) is associated with a 48% predicted probability of csPCa at biopsy with an AUC of 0.83, which was more accurate than either marker alone. A low IsoPSA in combination with a negative MRI resulted in a 98% chance of benign/indolent disease at biopsy. These findings may prove useful for the practicing Urologist and may help guide discussions regarding the need for biopsy when interpreting various IsoPSA/PIRADS combinations. [Table: see text]" @default.
- W4324137029 created "2023-03-15" @default.
- W4324137029 creator A5009963118 @default.
- W4324137029 creator A5020011166 @default.
- W4324137029 creator A5024614348 @default.
- W4324137029 creator A5032982262 @default.
- W4324137029 creator A5041743860 @default.
- W4324137029 creator A5058100277 @default.
- W4324137029 creator A5061362815 @default.
- W4324137029 creator A5070192160 @default.
- W4324137029 creator A5071053645 @default.
- W4324137029 creator A5084865365 @default.
- W4324137029 creator A5091808340 @default.
- W4324137029 date "2023-02-20" @default.
- W4324137029 modified "2023-09-27" @default.
- W4324137029 title "Use of IsoPSA with prostate MRI PIRADS score in biopsy decision making in patients with elevated PSA." @default.
- W4324137029 doi "https://doi.org/10.1200/jco.2023.41.6_suppl.388" @default.
- W4324137029 hasPublicationYear "2023" @default.
- W4324137029 type Work @default.
- W4324137029 citedByCount "0" @default.
- W4324137029 crossrefType "journal-article" @default.
- W4324137029 hasAuthorship W4324137029A5009963118 @default.
- W4324137029 hasAuthorship W4324137029A5020011166 @default.
- W4324137029 hasAuthorship W4324137029A5024614348 @default.
- W4324137029 hasAuthorship W4324137029A5032982262 @default.
- W4324137029 hasAuthorship W4324137029A5041743860 @default.
- W4324137029 hasAuthorship W4324137029A5058100277 @default.
- W4324137029 hasAuthorship W4324137029A5061362815 @default.
- W4324137029 hasAuthorship W4324137029A5070192160 @default.
- W4324137029 hasAuthorship W4324137029A5071053645 @default.
- W4324137029 hasAuthorship W4324137029A5084865365 @default.
- W4324137029 hasAuthorship W4324137029A5091808340 @default.
- W4324137029 hasConcept C121608353 @default.
- W4324137029 hasConcept C126322002 @default.
- W4324137029 hasConcept C126838900 @default.
- W4324137029 hasConcept C126894567 @default.
- W4324137029 hasConcept C143409427 @default.
- W4324137029 hasConcept C151956035 @default.
- W4324137029 hasConcept C2775934546 @default.
- W4324137029 hasConcept C2776235491 @default.
- W4324137029 hasConcept C2780192828 @default.
- W4324137029 hasConcept C2781217009 @default.
- W4324137029 hasConcept C58471807 @default.
- W4324137029 hasConcept C71924100 @default.
- W4324137029 hasConceptScore W4324137029C121608353 @default.
- W4324137029 hasConceptScore W4324137029C126322002 @default.
- W4324137029 hasConceptScore W4324137029C126838900 @default.
- W4324137029 hasConceptScore W4324137029C126894567 @default.
- W4324137029 hasConceptScore W4324137029C143409427 @default.
- W4324137029 hasConceptScore W4324137029C151956035 @default.
- W4324137029 hasConceptScore W4324137029C2775934546 @default.
- W4324137029 hasConceptScore W4324137029C2776235491 @default.
- W4324137029 hasConceptScore W4324137029C2780192828 @default.
- W4324137029 hasConceptScore W4324137029C2781217009 @default.
- W4324137029 hasConceptScore W4324137029C58471807 @default.
- W4324137029 hasConceptScore W4324137029C71924100 @default.
- W4324137029 hasIssue "6_suppl" @default.
- W4324137029 hasLocation W43241370291 @default.
- W4324137029 hasOpenAccess W4324137029 @default.
- W4324137029 hasPrimaryLocation W43241370291 @default.
- W4324137029 hasRelatedWork W1725314107 @default.
- W4324137029 hasRelatedWork W1979374145 @default.
- W4324137029 hasRelatedWork W2041562209 @default.
- W4324137029 hasRelatedWork W2047986592 @default.
- W4324137029 hasRelatedWork W2099948048 @default.
- W4324137029 hasRelatedWork W2102167265 @default.
- W4324137029 hasRelatedWork W2148869351 @default.
- W4324137029 hasRelatedWork W2390982334 @default.
- W4324137029 hasRelatedWork W3082324229 @default.
- W4324137029 hasRelatedWork W3171213747 @default.
- W4324137029 hasVolume "41" @default.
- W4324137029 isParatext "false" @default.
- W4324137029 isRetracted "false" @default.
- W4324137029 workType "article" @default.